Celyad Oncology SA: Celyad Oncology Announces Clinical Hold

Regulatory News: Celyad Oncology SA (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD) (Euronext Nasdaq: CYAD) (the "Company"), a clinical-stage biotechnology company focused on the discovery and development

Related Keywords

Paris , France General , France , Mont Saint Guibert , Waals Gewest , Belgium , New York , United States , Walloon Region , Sara Zelkovic , Exchange Commission , Communications Investor Relations , Lifesci Advisors , Drug Administration , Regulatory News , Euronext Nasdaq , Private Securities Litigation Reform Act , Celyad Oncology , Annual Report , Media Contacts , Investor Relations Director , Sci Advisors , Celyad , Ncology , Nnounces , Linical , Gold , Ryad , Hase , Trial ,